Published in Infect Immun on April 01, 2004
Bioluminescent imaging of Trypanosoma cruzi infection. Int J Parasitol (2008) 1.23
Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection. Cell Microbiol (2014) 1.14
Molecular mechanisms of host cell invasion by Trypanosoma cruzi. Exp Parasitol (2010) 1.04
Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi. Infect Immun (2006) 1.02
ECG detection of murine chagasic cardiomyopathy. J Parasitol (2010) 0.94
The liver plays a major role in clearance and destruction of blood trypomastigotes in Trypanosoma cruzi chronically infected mice. PLoS Negl Trop Dis (2010) 0.91
Cavia porcellus as a model for experimental infection by Trypanosoma cruzi. Am J Pathol (2011) 0.89
Distinct genetic control of parasite elimination, dissemination, and disease after Leishmania major infection. Immunogenetics (2009) 0.84
Trypanosoma cruzi: experimental parasitism in the central nervous system of albino mice. Parasitol Res (2012) 0.83
Chagas disease: still many unsolved issues. Mediators Inflamm (2014) 0.82
Evaluation of clinical and immunopathological features of different infective doses of Trypanosoma cruzi in dogs during the acute phase. ScientificWorldJournal (2012) 0.81
Genes from Chagas susceptibility loci that are differentially expressed in T. cruzi-resistant mice are candidates accounting for impaired immunity. PLoS One (2006) 0.81
The use of a heterogeneously controlled mouse population reveals a significant correlation of acute phase parasitemia with mortality in Chagas disease. PLoS One (2014) 0.80
A parent-of-origin effect determines the susceptibility of a non-informative F1 population to Trypanosoma cruzi infection in vivo. PLoS One (2013) 0.79
The Trypanosoma cruzi vitamin C dependent peroxidase confers protection against oxidative stress but is not a determinant of virulence. PLoS Negl Trop Dis (2015) 0.77
Challenge of chronically infected mice with homologous trypanosoma cruzi parasites enhances the immune response but does not modify cardiopathy: implications for the design of a therapeutic vaccine. Clin Vaccine Immunol (2012) 0.77
Exacerbated skeletal muscle inflammation and calcification in the acute phase of infection by Mexican Trypanosoma cruzi DTUI strain. Biomed Res Int (2014) 0.75
Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol (2002) 1.88
Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J Infect Dis (1999) 1.84
Tissue tropism of different Trypanosoma cruzi strains. J Parasitol (1978) 1.83
Trypanosoma cruzi: role of the immune response in the natural resistance of inbred strains of mice. Exp Parasitol (1978) 1.82
Myocardial parasite persistence in chronic chagasic patients. Am J Trop Med Hyg (1999) 1.75
Parasite persistence in the aetiology of Chagas disease. Int J Parasitol (2001) 1.67
Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. Am J Pathol (2000) 1.52
Genetics of murine resistance to Trypanosoma cruzi. Infect Immun (1982) 1.51
Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol (1999) 1.49
Differential tissue distribution of diverse clones of Trypanosoma cruzi in infected mice. Mol Biochem Parasitol (1999) 1.45
Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J Exp Med (2000) 1.35
Genetic control of responses to Trypanosoma cruzi in mice: multiple genes influencing parasitemia and survival. Infect Immun (1982) 1.34
PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease. Lancet (1996) 1.26
Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Invest (1996) 1.22
Persistent production of inflammatory and anti-inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infections. Exp Parasitol (1996) 1.21
Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease. Infect Immun (1999) 1.08
Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens. Ann Trop Med Parasitol (2000) 1.05
Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc Pathol (2000) 1.05
Identification of two cerebral malaria resistance loci using an inbred wild-derived mouse strain. Proc Natl Acad Sci U S A (2002) 1.03
Dual role for transforming growth factor beta-dependent signaling in Trypanosoma cruzi infection of mammalian cells. Infect Immun (2000) 1.01
Is TNF alpha involved in early susceptibility of Trypanosoma cruzi-infected C3H/He mice? Res Immunol (1991) 0.98
Neuropathy associated with experimental Chagas' disease. Ann Neurol (1985) 0.98
Trypanosoma cruzi: immunological consequences of parasite modification of host cells. Clin Exp Immunol (1980) 0.98
Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop (2002) 0.97
[Pathology of prolonged experimental Chagas' disease]. Rev Inst Med Trop Sao Paulo (1970) 0.94
Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. J Autoimmun (2002) 0.93
Murine susceptibility to Chagas' disease maps to chromosomes 5 and 17. Genes Immun (2003) 0.92
A heart-specific CD4+ T-cell line obtained from a chronic chagasic mouse induces carditis in heart-immunized mice and rejection of normal heart transplants in the absence of Trypanosoma cruzi. Parasite Immunol (2001) 0.89
Molecular diagnosis of Chagas' disease and use of an animal model to study parasite tropism. Parasitol Res (2003) 0.86
Chronic Chagas disease in the mouse. I. Electrocardiographic and morphological patterns of the cardiopathy. Medicina (B Aires) (1981) 0.83
Trypanosoma cruzi: constancy of clone pathogenicity for inbred mice during long-term in vitro maintenance. Trans R Soc Trop Med Hyg (1986) 0.78
The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma. J Immunol (2005) 1.35
Macrophages from IL-12p40-deficient mice have a bias toward the M2 activation profile. J Leukoc Biol (2002) 1.17
Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase. Hum Gene Ther (2004) 1.14
Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi. Infect Immun (2006) 1.02
What kind of message does IL-12/IL-23 bring to macrophages and dendritic cells? Microbes Infect (2004) 1.02
Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice. Diabetes (2007) 0.95
Role of CD28 in polyclonal and specific T and B cell responses required for protection against blood stage malaria. J Immunol (2005) 0.93
Role of endogenous IFN-gamma in macrophage programming induced by IL-12 and IL-18. J Interferon Cytokine Res (2007) 0.92
The liver plays a major role in clearance and destruction of blood trypomastigotes in Trypanosoma cruzi chronically infected mice. PLoS Negl Trop Dis (2010) 0.91
Inhibitory effects of beta-carotene and vitamin a during the progression phase of hepatocarcinogenesis involve inhibition of cell proliferation but not alterations in DNA methylation. Nutr Cancer (2002) 0.89
The spleen CD4+ T cell response to blood-stage Plasmodium chabaudi malaria develops in two phases characterized by different properties. PLoS One (2011) 0.86
Infection by the Sylvio X10/4 clone of Trypanosoma cruzi: relevance of a low-virulence model of Chagas' disease. Microbes Infect (2009) 0.86
Genetic transformation of cork oak (Quercus suber L.) for herbicide resistance. Biotechnol Lett (2009) 0.84
Impaired macrophage responses may contribute to exacerbation of blood-stage Plasmodium chabaudi chabaudi malaria in interleukin-12-deficient mice. J Interferon Cytokine Res (2002) 0.83
Liver accumulation of Plasmodium chabaudi-infected red blood cells and modulation of regulatory T cell and dendritic cell responses. PLoS One (2013) 0.83
Cytotoxic effects of mistletoe (Viscum album L.) in head and neck squamous cell carcinoma cell lines. Oncol Rep (2013) 0.82
Allogeneic apoptotic thymocyte-stimulated dendritic cells expand functional regulatory T cells. Immunology (2011) 0.81
Cellular renewal and improvement of local cell effector activity in peritoneal cavity in response to infectious stimuli. PLoS One (2011) 0.81
Challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes activates the immune system and reduces subpatent parasitemia levels. J Parasitol (2004) 0.80
Anti-IL-2 treatment impairs the expansion of T(reg) cell population during acute malaria and enhances the Th1 cell response at the chronic disease. PLoS One (2012) 0.77
MyD88 signaling is directly involved in the development of murine placental malaria. Infect Immun (2013) 0.76